Development of a human mammary epithelial cell culture model for evaluation of drug transfer into milk

Archives of Pharmacal Research

Volumn 29, Issue 5, 2006, Pages 424-429

  Kimura, Soichiro ^a   Morimoto, Keiko ^a   Okamoto, Hiroshi ^a   Ueda, Hideo ^a   Kobayashi, Daisuke ^a,b   Kobayashi, Jun ^a   Morimoto, Yasunori ^a,b  

^a JOSAI UNIVERSITY   (Japan)

^b Research Institute of TTS Technology   (Japan)

Author keywords

Carrier mediated drug transport; Differentiation; Human mammary epithelial cell; Trypsin resistant cells

Indexed keywords

CASEIN; MESSENGER RNA; ORGANIC CATION TRANSPORTER; ORGANIC CATION TRANSPORTER 1; SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 3; TETRYLAMMONIUM; TRYPSIN;

ARTICLE; BREAST MILK; CELL DIFFERENTIATION; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; DRUG SCREENING; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LACTATION; MAMMARY GLAND; METABOLISM; METHODOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CASEINS; CELL DIFFERENTIATION; CELL LINE; DRUG EVALUATION, PRECLINICAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; LACTATION; MAMMARY GLANDS, HUMAN; MILK, HUMAN; ORGANIC CATION TRANSPORT PROTEINS; ORGANIC CATION TRANSPORTER 1; RNA, MESSENGER; TETRAETHYLAMMONIUM; TRYPSIN;

EID: 33744942649     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02968594     Document Type: Article

References (24)

1. Adson, A., Raub, T. J., Burton, P. S., Barsuhn, C. L., Hilgers, A. R., Audus, K. L., and Ho, N. F., Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers. J. Pharm. Sci., 83, 1529-1536 (1994).
2. Alcorn, J., Lu, X., Moscow, J. A., and McNamara, P. J., Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction. J. Pharmacol. Exp. Ther., 303, 487-496 (2002).
3. American Academy of Pediatrics, Committee on Drugs, The transfer of drugs and other chemicals into human milk. Pediatrics, 108, 776-789 (2001).
4. American Academy of Pediatrics, Work Group on Breastfeeding, Breastfeeding and the use of human milk. Pediatrics, 100, 1035-39 (1997).
5. Anderson, P. O., Drug use during breastfeeding. Clin. Pharm.,10, 594-624 (1991).
6. Bennett, P. N. (ed), Drugs and Human Lactation, 2nd edition. Elsevier, Amsterdam (1996).
7. Berga, S. E., Electrical potentials and cell-to-cell dye movement in mouse mammary gland during lactaion. Am. J. Physiol., 247, C20-C25 (1984).
8. Fleishaker, J. C., Desai, N., and McNamara, P. J., Factors affecting the milk-to-plasma drug concentration ratio in lactating women: physical interactions with protein and fat. J. Pharm. Sci., 76, 189-193 (1987)
9. Fleishaker, J. C., Models and methods for predicting drug transfer into human milk. Adv. Drug Deliv. Rev., 55, 643-652 (2003)
10. Food and Drug Administration (US), 2005, Guidance for Industry, Clinical Lactation studies - study design, data analysis, and recommendations for labeling.Maryland, Available from: http://www.fda.gov/cder/guidance/index.htm.
11. Gerk, P. M., Kuhn, R. J., and McNamara, P. J., Active transport of nitrofurantoin into human milk. Pharmacotherapy, 21, 669-675 (2001).
12. Gerk, P. M., Moscow, J. A., and McNamara, P. J.,Basolateral active uptake of nitrofurantoin in the CIT3 cell culture model of lactation. Drug Metab. Dispos., 31, 691-693 (2003).
13. Ito, S. and Lee, A., Drug excretion into breast milk overview. Adv. Drug Deliv. Rev., 55, 612-617 (2003).
14. Linzell, J. L. and Peaker, M., The permeability of mammary ducts. J. Physiol., 201, 701-716 (1971).
15. Linzell, J. L. and Peaker, M., Changes in colostrums composition and in the permeability of the mammary epithelial at about the time of parturition in the goat. J. Physiol., 243, 129-151 (1974).
16. Marks, G. J., Ryan, F. M., Hidalgo, I. J., and Smith, P. L., Mannitol as a marker for intestinal integrity in in vitro absorption studies. Gastroenterology, 100, suppl, A697 (1991).
17. McManaman, J. L. and Neville, M. C., Mammary physiology and milk secretion. Adv. Drug Deliv. Rev., 55, 629-641 (2003)
18. McNamara, P. J., Burgio, D., and Yoo, S. D., Pharmacokinetics of cimetidine during lactation: species differences in cimetidine transport into rat and rabbit milk. J. Pharmacol. Exp. Ther., 261, 918-923 (1992).
19. Neville, M. C., Morton, J., and Umemura, S., Lactogenesis: the transition from pregnancy to lactation. Pediatr. Clin. North Am., 48, 35-52 (2001)
20. Oo, C. Y., Kuhn, R. J., Desai, N., and McNamara, P. J., Active transport of cimetidine into milk. Clin. Pharmacol. Ther., 58, 548-555 (1995).
21. Schmidhauser, C., Bissell, M. J., and Myers, C. J., Casperson, F. G., Extracellular matrix and hormones transcriptionally regulate bovine â-casein 5′ sequences in stably transfected mouse mammary cells. Proc. Natl. Acad. Sci. U.S.A., 87, 9118-9122 (1990).
22. Shipman, L. J., Docherty, A. H., Knight, C. H., and Wilde, C. J., Metabolic adaptations in mouse mammary gland during a normal lactation cycle and in extend lactation. Q. J. Exp. Physiol., 72, 303-311 (1987).
23. Toddywalla, V. S., Kari, F. W., and Neville, M. C., Active transport of nitrofurntoin across a mouse mammary epithelial monolayer. J. Pharmacol. Exp. Ther., 280, 669-676 (1997).
24. Wilson, J. T., Determinants and consequences of drug excretion in breast milk. Drug Metab. Rev., 14, 619-652 (1983).